Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Danish Medical Journal

Retrograde cricopharyngeal dysfunction management with botulinum toxin A

View Full Paper
Ask AI
Bookmark
Share

Authors

DLDalia Gustaityté LarsenMAMathilde AallingNUNichlas Udholm

Discussion

Loading...

Member takes

Overview

Retrospective case series evaluates botulinum toxin A effects on symptom relief in R-CPD patients, highlighting potential for improved outcomes.

Key Points

  • Botulinum toxin A treatment led to symptom relief in 35 out of 40 R-CPD patients within two weeks.
  • Of 31 patients followed long-term, 18 continued to belch after three months, suggesting lasting effectiveness.
  • Patients treated with higher doses of botulinum toxin A reported improved outcomes, indicating dose response.
  • Adverse effects were minimal, with only transient dysphagia and mild sore throat reported.

Cite This Study

Larsen et al. (2025) studied this question.

synapsesocial.com/papers/68c1a27254b1d3bfb60dde9fhttps://doi.org/10.61409/a03250166
View Full Paper
Ask AI
Bookmark
Share